We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On 27 September 2010, the Indonesian competition regulator ('KPPU') imposed a record fine of IDR 25 billion on PT Pfizer Indonesia and IDR 20 billion (S$3 million) on PT Dexa Medica for fixing the price of amlodipine tablets, a drug used to treat high blood pressure, in Indonesia
